Georgetown Lombardi, Washington's only NCI-designated Comprehensive Cancer Center, is an approved research consortium with the John Theurer Cancer Center/Hackensack Meridian Health in New Jersey.
We are developing and testing the cancer treatments of tomorrow - targeted therapies that will improve both survival and quality of life.
Award-winning physicians, state-of-the-art facilities, and a high commitment to excellence—qualities that make Lombardi stand out above the rest!
Educating and training tomorrow's leaders in cancer treatment and research is our mission.
Discover what distinguishes Georgetown Lombardi Comprehensive Cancer Center,
Washington, D.C.’s only National Cancer Institute-designated Comprehensive Cancer Center.
Georgetown University President John J. DeGioia discusses the significance of Georgetown Lombardi's research.
Meet 
Georgetown University Medical Center is an internationally recognized academic health and science center with a four-part mission of research, teaching, service and patient care (provided through a partnership with MedStar Health).
Lombardi News Stories
-
Revealing the Molecular Engine That Drives Pancreatic Cancer Provides Ways to Turn It Off
-
Recognizing the Toll of Oral Damage From Graft-Versus-Host Disease After Stem Cell Transplant
-
Georgetown Lombardi Receives Transformational NCI Grant to Support Community Outreach and Research
-
The Arts Through the Lens of Health Care at Georgetown Lombardi